There is much interest in incorporating knowledge of biological mechanisms of carcinogenesis into assessments of health risks to humans posed by chemicals in the environment. Debate over the soundness of using data from animal bioassays conducted at minimally toxic doses or fractions thereof for predicting cancer risks to humans exposed to much lower doses has stimulated interest in the question of whether genotoxic or mitotic effects predominate in chemical carcinogenesis. Cell division plays a key role at each stage in the evolution of cancer, and it is well documented that increased rates of cell proliferation can escalate the risk of malignancy. This article examines the current understanding of both mechanisms by which chemicals provoke cell proliferation and the contribution of various kinetic patterns of cell proliferation to carcinogenesis.
Introduction
Malignant transformation is a complex process involving multiple genetic changes that result in uncontrolled patterns of cell growth. Dividing cells are at increased risk for both spontaneous genetic damage as well as that induced by genotoxic agents. Thus, chemical or physical agents that cause damage to DNA and/or increase the rate of cell division also increase the probability of the occurrence of important genetic changes leading to cancer.
The circumstances in which genotoxic or mitogenic activities predominate in the cancer process has recently stimulated debate concerning the soundness of using data from high-dose animal bioassays for the purpose of predicting cancer risk to humans. In the absence of mechanistic information, the EPA and other regulatory agencies currently follow the conservative assumption that cancer incidence decreases (or increases) linearly with dose throughout the entire range of possible exposures (1) . There are, however, an increasing number of examples of nonlinear doseresponse relationships in which the slope of the doseresponse curve was found to change dramatically at ENSR Consulting and Engineering, 35 Nagog Park, Acton, MA 01720.
higher doses (2) . Changes in a number of factors including pharmacokinetics, metabolism, and toxic effects have been associated with such dose-related changes in cancer potency. Chemically induced cell proliferation is one such factor that is of particular interest with regard to determination of cancer potency relationships for chemicals that have genotoxic effects, as well as so-called nongenotoxic chemicals (those not directly reactive with DNA) for which a direct cause and effect relationship with genetic change is lacking.
There is conflicting evidence as to whether chemically induced cell proliferation per se can increase the risk of neoplastic transformation. One view contends that an increased rate of cell division is primarily responsible for the carcinogenic effects of many nongenotoxic chemicals. Ames and Gold (3) , for example, have suggested that many chemicals observed to cause tumors in rodents act indirectly by stimulating cell proliferation that, in turn, increases both the likelihood that endogenous DNA damage will produce mutations and the number of cells at risk for progressive changes in gene expression that lead to malignancy. On the other hand, it has been pointed out that hematopoietic tissues and the small intestine, both of which have high rates of cell proliferation, have a low incidence of tumors (4) . This 
Role of Cell Proliferation in Carcinogenesis
Chemical carcinogenesis has been empirically divided into sequential steps or stages in which cells progress from normal to premalignant foci to localized tumors and to invasive, malignant growths (5) . There is little disagreement that cell proliferation plays a key role in each stage of tumor formation. The first step in the sequence of events that transforms a normal cell to malignancy has been termed initiation. Initiated cells have been permanently altered so as to have the potential to express the malignant phenotype. Additional steps (stages) in tumor formation have been termed "promotion" and "progression." Promotion involves reversible changes in cell populations within a tissue that place initiated cells at increased risk for further genetic changes. Progression occurs when changes in the cell's genetic program produce irreversible characteristics of the malignant phenotype.
More than one genetic change may be required to complete each stage in the carcinogenic process. In human colon carcinogenesis, specific genetic alterations have been related to different stages in the evolution of malignancy (6) . Such genetic changes could not occur and would not be expressed in the absence of DNA replication and cell division. It seems likely that a variety of treatments that accelerate the carcinogenic process do so through their ability to increase cell division. Treatments such as partial hepatectomy that induce cell proliferation greatly enhance the appearance of preneoplastic foci and hepatocellular carcinomas in the livers of rats treated with carcinogenic chemicals (7) . The (8, 9) . Such random errors are thought to account for the incidence of spontaneously initiated cells in the livers and other organs of control animals. It has been suggested that hyperplasia per se can increase the probability of genetic change by increasing the likelihood of mutations arising from normal DNA replication processes or the conversion of DNA lesions produced by oxygen radicals formed endogenously to mutations (3, 10) . Various estimates have been made of the amounts of spontaneous DNA damage suffered by rats and humans (11, 12) , but to date, there have been no estimates of the frequency of mutations caused by such DNA damage. Thus, the significance of DNA damage resulting from endogenous reactants such as oxygen radicals remains speculative.
For many nongenotoxic or weakly genotoxic chemicals, the ability to induce cell proliferation is believed to be a critical factor for the development of tumors in experimental animals (13, 14) . Some evidence suggests, however, that chemicals that accelerate the promotion and progression stages of carcinogenesis do more than simply increase the rate of cell proliferation. Various phorbol esters, for example, reportedly block differentiation of keratinocytes (15) and can indirectly produce physical damage to cellular DNA (16, 17) . In the rat liver, phenobarbital prevents the death of cells in altered foci of hepatocytes (18) . Thus, although the ability to induce cell proliferation appears to be necessary for tumor development, it may not be sufficient. There are, in fact, several reports (discussed below) of animal experiments in which increased cell proliferation inhibited or had no observable effect on tumor formation.
Despite these exceptions, the ability of chemicals to increase the rate of cell proliferation in tissues has emerged as an important factor that can influence estimates of carcinogenic potencies. Furthermore, accumulating epidemiological evidence points to increased cell division as an important factor in the pathogenesis of many human cancers (19 Figure 1 shows that different dose relationships were observed for liver and bladder tumors in female BALB/c mice fed 2-acetylaminofluoreiie (AAF) in the diet for 24 months (20, 21) . The incidence of liver cancer showed a linear relationship with dietary concentration of AAF, whereas a sharp increase occurred in the slope of the dose-response curve for bladder tumors at approximately 60 ppm. AAF is a potent genotoxin, which would be expected to be the primary basis for its tumorigenic effects. But, as discussed below, in some circumstances the likelihood of bladder cancer from AAF appears to be primarily determined by its cytotoxic effects.
Experimental bladder carcinogenesis has provided several examples for which hyperplasia was associated with nonlinear dose-response relationships. Chronic exposures to the genotoxic chemicals 2-acetylaminofluorene (AAF) and N-[-4-(5-nitro-2-furyl)-thiazoyl]formamide (FANFT) have been shown to produce bladder cancer in mice (22, 23) . In the case of AAF, a sharp increase in bladder tumors (see Fig. 1 ) was observed in animals receiving 60 ppm AAF in the diet. However, the concentration of AAF adducts in bladder DNA was found to be a linear function of dose over a range of 5-150 ppm AAF in the diet (24) . The amount of promutagenic DNA damage was related linearly with dose, but tumor formation was not. With both AAF and FANFT, the sharp increase in the dose response for tumor formation occurred at doses that resulted in toxic and proliferative effects on the bladder epithelium. Littlefield et al. (22) AAF does, in fact, produce a nonlinear tumor response in the liver at doses greater than used in the study described above. At higher dietary concentrations, AAF produces overtly cytotoxic effects in the liver, resulting in compensatory proliferation and a sharp increase in the rate of tumor formation (27) . Perhaps other chemicals would show the same pattern of tumor response if tested over such a large range of doses.
Peto et al. (28) examined the incidence of liver cancer in rats exposed to drinking water containing 0.4-40 ppm diethylnitrosamine (DEN) and found a nonlinear response. A sharp increase in the cancer potency of DEN for liver tumors occurred at approximately 4 ppm DEN. The increased cancer potency of DEN concentrations greater than 4 ppm was not due to enhanced genotoxic effects. Investigations by Boucheron et al. (29) found that continuous exposure to DEN resulted in the concentration-dependent accumulation of promutagenic adducts in DNA over a similar range of drinking water concentrations. Further investigations by Deal et al. (30) found that exposure to drinking water containing 4 ppm or greater DEN resulted in cytotoxic effects and increased cell proliferation in the target tissue. At 4 ppm DEN there was a 3-fold increase in hepatocyte replication after 10 weeks; 100 ppm DEN led to a 15-fold increase. They suggested that the increased rate of hepatocyte proliferation was a major factor relating the nonlinear tumor response to the linear accumulation of DNA adducts.
These experimental findings indicate that genotoxic carcinogens are likely to display their most potent effects in the range of doses for which both genotoxic and proliferative effects coincide. Outside this range tumor response will be diminished. At high doses, lethal effects can result in the destruction of initiated cells and a reduction in the predicted incidence of tumors. Low doses that do not increase normal rates of cell proliferation will not provide greater opportunity for genetic changes required to advance initiated cells through the later stages of neoplasia. In this latter case, disturbances in the control of cell proliferation may have a crucial role in tumor development.
Nonlinear dose-response relationships have also been observed for carcinogenic substances that do not directly damage DNA. Unleaded gasoline produced kidney tumors in male rats at doses that cause epithelial cell death and regenerative proliferation in the proximal tubule-doses that did not cause cell injury did not cause tumors (31) . Bladder tumorigenesis in rats by sodium saccharin requires doses sufficiently high to form urinary calculi that result in focal hyperplasia (32) . Dose-related effects have also been documented for tumor promoters on mouse skin. Verma and Boutwell (33) reported that repeated application of less than 1.0 nmole of 12-O-tetradecanoylphorbol- 13 
Proliferative Responses to Cytotoxic Damage
Rodent liver has received the most attention with respect to the identity of tissue-specific factors involved in proliferative response to injury. In the adult liver, hepatocytes rarely divide except in response to injury or xenobiotics. The identity of polypeptide factors that mediate liver regeneration is an active area of research. Several groups of investigators have identified related polypeptide growth factors that may be involved in regenerative growth of the liver after partial hepatectomy or after injury from toxic chemicals. This factor, which has been referred to as hepatocyte growth factor (34) , hepatopoietin A (35), or hepatotropin (36) promotes DNA synthesis and cell division in primary cultures of rat hepatocytes.
The concentration of hepatocyte growth factor (HGF) has been found to increase dramatically in the liver after physical injury and hepatitis caused by infectious agents or chemicals. HGF has been identified in the plasma of patients with fulminant hepatic failure (37) . It has also been found to be markedly increased in the livers of rats that suffered necrotic injury resulting from treatment with CC14 (38) . After CC14 injury, there is a rapid rise in the level of HGF transcript in nonparenchymal cells (principally Kupffer cells), but not in hepatocytes (39) . Further evidence of the role of HGF in liver regeneration has been provided by Higuchi et al. (40) , who recently identified a receptor on the surface of rat hepatocytes that binds HGF with high affinity. Rapid disappearance (downregulation) of HGF receptors from the cell membrane as a result of internalization of HGF-receptor complexes occurred in response to partial hepatectomy or CCl4-induced hepatitis. This suggests that Kupffer cells are crucial to the liver's ability to replace cells that are damaged or lost.
The discovery of HGF stimulated speculation about the existence of a variety of tissue-specific growth factors. Further investigations, however, have evidenced a more general role for HGF in proliferative responses in extrahepatic tissues. Gherardi and Stoker (41) (47) . Combinations of growth factors are also implicated in the regenerative growth of the skin after injury by toxic chemicals. Akhurst et al. (48) have reported evidence of localized production of TGF-1 in stimulated mouse epidermis. Keratinocytes also both produce and respond to a number of growth factors including the cytokines interleukin 6 (IL-6) and interleukin l(IL-1) as well as transforming growth factor a(TGF-a). High levels of both IL-6 and TGF-a have been found in activation of epidermal cell growth in psoriatic skin (49, 50 (56) . The results of further experiments suggested that PB's ability to decrease the rate of cell death (apoptosis) was primarily responsible for increased cell proliferation in foci (18, 57) . Thus, PB's effects on the rates of birth and death of normal and preneoplastic liver cells result in the preferential growth and accumulation of cells that are at greater risk for tumorigenic transformation. There is genetic evidence that PB interacts with an intracellular receptor, but it has been difficult to obtain biochemical evidence to confirm the receptor's existence.
Interaction with intracellular molecules underlies the ability of several chemicals to stimulate cell division and fuel the cancer process. Activation of the estrogen receptor seems to mediate the liver's mitotic response to estrogenic compounds. Tumor promoters such as 17 a-ethinylestradiol interact with intracellular receptors resulting in responses similar to those triggered by endogenous hormones (58, 59 ). The basis of dioxin's ability to induce epidermal hyperplasia, among other effects, is its interaction with the Ah receptor (60) . Similarly, TPA and related phorbol esters that are effective tumor promoters bind to and activate protein kinase C (PKC), resulting in the stimulation of signal transduction pathways (61) .
How can we develop a better understanding of the ways in which chemicals stimulate cell division? The paradigm that both toxic and nontoxic doses of chemicals cause cell proliferation through diverse receptormediated processes suggests a strategy for developing an understanding of both the qualitative and quantitative aspects of this response. For (62) . There are a number of reasons to suspect a link between the induction of HSP and stressinduced cell proliferation. The evidence for this connection has recently been reviewed by Pechan (63) . An intriguing finding is that one of the two prominent 70 kD HSPs is induced just before S phase when quiescent serum-starved cells are fed again (64) . The HSP- 70 protein has also been implicated in cellular responses to peroxisome proliferators (65) . In relation to cytotoxic chemicals, it has been reported that the antitumor drug 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), which carbamoylates proteins and nucleic acids, selectively induced the synthesis of the human heat shock and stress-induced genes HSP-90 and HSP-70 (66) .
The biochemical activities of HSPs are well suited for diverse roles in the assembly and function of cellular molecules. The ability of various HSPs to recognize denatured or abnormally folded proteins is believed to be essential for induction of both stress responses and a number of essential roles of HSP proteins in cellular processes that occur during normal growth and development (67) . Although a number of specific roles for HSPs in cell proliferation have been proposed, none is certain as yet. It is certain, however, that continued investigation of the HSPs will uncover more diverse roles for these proteins in normal and injured cells. Even without knowing the precise mechanisms, any understanding that we gain will contribute to our ability to evaluate the proliferative potential of unknown chemicals, given the types of cytotoxic damage they can inflict. Columbano et al. (68) (69) (70) found that intermittent administration of any of the three liver mitogens ethylene dibromide (EDB), lead nitrate, and nafenopin did not promote DEN-initiated hepatocytes. They observed no increase in the number of preneoplastic foci in animals that had received four consecutive treatments of these chemicals in which four daily intragastric doses were given every 20 days (70) . The same chemicals were also found to be ineffective during the initiation stage of the carcinogenic process when given just before a small dose of a genotoxic chemical (69) . In contrast, intermittent treatment with CC14 or partial hepatectomy, which induced comparable levels of DNA replication and mitosis, produced numerous preneoplastic foci in the livers of DEN-treated rats (69) .
In explaining their negative findings for the three mitogens, Columbano et al. (69, 70) suggested that any initiated cells formed during the mitotic response were eliminated when the chemical was withdrawn. Instead of a sustained increased in cell number, the chemical treatments resulted in cycles of cell growth and death in the liver. An increase in liver size (increased liver/body weight ratio) occurred during and shortly after administration of the four daily intragastric doses. In the interim periods between these treatments, liver size returned to normal through apoptosis (68, 71 Argyris (73) , the ability of a treatment to elicit a sustained regenerative hyperplasia is decisive in determining its effectiveness as a tumor promoter. Efficient tumor promoting substances such as TPA produce a persistent hyperplastic response with continued treatment. In contrast, acetic acid and mezerine, which are ineffective promoters, initially produce an epidermal hyperplasia that is comparable to that seen with TPA, but repeated treatment results in a diminution of response and reduced mitotic activity. These results indicate that proliferative response alone may give a false indication of a chemical's potential to act as a tumor promoter in mouse skin.
The contrasting effects of the two phorbol esters TPA and retinoylphorbol acetate (RPA) on mouse skin tumorigenesis provide another example of the complex relationship between cell proliferation and carcinogenesis in mouse skin (74) . Both TPA and RPA induce hyperplasia, but RPA is ineffective in promoting the early stages of malignant transformation in NMRI and CD-1 strains of mice. In Sencar mice, however, RPA was found to be an effective tumor promoter of skin tumors (75) . Thus, there are strain-specific differences in response to these compounds, the basis of which is not understood.
In the rat forestomach, the ability of chemicals to cause irritation and resultant hyperplasia of the epithelium has been clearly associated with the tissue's potential tumorigenic response. A number of chemicals without demonstrable genotoxic activity, including butylated hydroxyanisole (BHA), propionic acid, sodium saccharin, diallyl phthalate, and possibly ethyl acrylate have been shown to induce cancers in the forestomach of the rat. Experimental studies with BHA have shown a correlation between levels in the diet that induce inflammation and hyperplasia of the forestomach epithelium and those that cause tumors (76) . At high levels in the diet (2%), BHA induced both papillomas and carcinomas of the forestomach. Lower levels (0.5%) were noncarcinogenic by themselves, but were found to induce hyperplasia and promote forestomach carcinomas initiated with N-methyl-N'-nitrosoguanidine (NMNG) (77) .
Other data, however, raise questions concerning the mechanism(s) by which BHA and other chemicals act as promoters in the rat forestomach. Wada et al. (78) have reported preliminary evidence suggesting that all chemicals that produce forestomach hyperplasia are not capable of promoting neoplasia. They reported that p-methoxyphenol (PMP) administered in the diet induced a strong hyperplastic response in the rat forestomach, but failed to promote NMNG-initiated tumors. The authors suggested that PMP may adversely affect the carcinogenic process through its cytotoxic effects, induce the "wrong type" of hyperplasia, or that PMP metabolites may be anticarcinogens (78) .
Another interpretation of the results of Wada et al. (78) is suggested by the observations of Rodriguez et al. (79) , who found diverse responses of the rat forestomach to various phenols and acids. It was observed that while BHA affected the prefundic area of the forestomach, PMP had its principle effect on the cells in the midregion. Thus, PMP's proliferative effects may not be directed at the DEN-initiated cells in the prefundic area that were most at risk for neoplastic transformation. The independence of genotoxic and cytotoxic effects has been evidenced with other chemical carcinogens.
Proliferative and genotoxic effects in different cell populations in the same tissue have emerged as an important factor determining tumorigenic responses to 4-(N-methyl-N-nitrosamino)-1-(2-pyridyl)-1-butanone (NNK) in rats. NNK is a major carcinogen found in tobacco products and has produced a high incidence of tumors in the nasal cavity, liver, and lungs of rats (80) . In both the liver and nasal cavity, marked increases in cell proliferation due to cytotoxic effects of NNK dramatically affect tumor formation (81) . In the nasal cavity, susceptibility to the genotoxic and cytotoxic effects of NNK varies considerably between cells located in the respiratory and olfactory mucosa. Low doses of NNK that do not produce toxic effects in the nasal cavity preferentially damage DNA in cells located in the respiratory mucosa. Thus, at low doses one would predict these cells to be at greatest risk of cancer. At high doses the amount of genotoxic damage produced by NNK was similar in both the olfactory and respiratory mucosa, but the olfactory region suffered the greatest cytotoxic effect. Proliferative changes with cellular transformation and progression to neoplasia were most prevalent in the olfactory region coincident with cytotoxic damage. Therefore, in the nasal cavity, toxic effects that produced a marked increased in cell proliferation dramatically affected tumor incidence in cells at similar risk for genetic damage. Belinsky et al. (80) speculated that the steep dose-response curve for induction of tumors by NNK as well as the localization of tumors can be explained by the difference in sensitivity to its cytoxicity. At low doses the greatest relative risk of cancer was shifted from cells that were most sensitive to NNK's cytotoxic effects to those most sensitive to its genotoxic effects. Such a relationship would not be predicted if only the genotoxic effect of NNK on the respiratory and olfactory mucosa was considered.
In the rat lung also, the cell type at highest risk for malignancy from NNK exposure is apparently not that at greatest risk for genetic damage. The highest level of DNA adducts in the lungs of NNK-treated rats occurred in the nonciliated bronchiolar epithelial (Clara) cells (82) . The Witschi (85) , however, provided evidence to the contrary. He demonstrated that BHT's proliferative effect, but not its ability to enhance lung tumorigenesis, was dependent on its metabolism by mixed-function oxidases. Inhibitors of these enzymes or other treatments that prevented BHT's metabolism reportedly eliminated its proliferative effects on lung tissue, but had no effect on its ability to promote previously initiated cells in the lung (85) . The exact basis of BHT's promoting effect is unknown. As in the case of PB, it is possible that BHT affects apoptosis of initiated lung cells or has other effects on specific cell types that were not apparent in Witschi's experiments.
The studies just described provide several examples of the complex relationships between genotoxic and cytotoxic effects in different cell types within the same tissues. These findings lend some support to the views by Ames and Gold (3, 10) What data will be needed to formulate models that better reflect the collaboration between genetic damage and cell proliferation in chemical carcinogenesis? First of all, knowledge of the mechanisms governing the regulation of growth factors, their receptors, and how growth factor-receptor interactions determine proliferative responses to cytotoxicity will be essential. Findings from in vitro studies point the way to important parameters that determine the intensity of proliferative responses. These include the duration of interaction between a growth factor and its receptor, and the number of such interactions that occur on the cell's surface-the latter depending both on the affinity of the growth factor for the receptor and the factor's concentration in the cell's environment (87) There are several important ways that these mathematical models can help us understand various aspects of the cancer process. Refinement of current mathematical models of carcinogenesis that incorporate chemically induced cell proliferation will point to key areas for further molecular investigations. In addition, pursuit of the molecular basis of a cell's proliferative response to chemicals will contribute to a better understanding of the bases of species sensitivity and tissue specificity in chemical carcinogenesis. Cohen and Ellwein (26) , in their recent article on the consequences of chemically induced cell proliferation in cancer, summarized their views on the role of mathematical models as follows:
It should be obvious that the real contribution of modeling is enhanced insight, not numbers. In terms of human risk assessment, the existence of a non-effect threshold, for example, cannot be ruled in or out on the basis of model analyses. Only experimental mechanism studies can provide the information base necessary to predict biological response discontinuities between high-and low-dose response. This is a good perspective to keep in mind. More sophisticated mathematical models are unlikely to provide certain evidence on which to base regulatory deci- It may be difficult, however, to resolve when and how different patterns of chemically induced cell proliferation influence tumor formation. Few doseresponse relationships for both cell proliferation and tumorigenesis have been examined for chemical carcinogens at doses much lower than those customarily used in rodent bioassays. Thus, most views concerning the contribution of chemically induced cell proliferation to tumor formation are based on results of a few studies for which contradictory evidence exists. In the absence of knowledge at the molecular level of how chemicals influence cell growth and how distinct growth patterns affect various stages of the cancer process, it will be difficult to accurately assess the relative contributions of genotoxic and proliferative effects on the cancer process and predict how they will vary with dose.
Although descriptive rodent bioassays could conceivably solve this problem, the expense of such studies is prohibitive. Furthermore, descriptive studies would not resolve the uncertainties inherent in interspecies extrapolation, a major reason for uncertainty when human risk assessments are based on rodent bioassay data. As we gain a better understanding of many fundamentals of the cancer process, we can envision key pieces of the puzzle that will enable us to better assess cancer risk to humans posed by chemicals in the environment. Future research that concentrates on understanding the basic molecular mechanisms by which tissues control their size and shape and how they respond and adapt to chemical injury will provide this essential information.
